Delivery Order SPE2DB22D1017-SPE2DB24FF8MJ
Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,055.53 firm fixed-price delivery order is for the medication Myrbetriq ER 50 mg tablets and has a completion date of July 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a broad range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,349.49, is for the delivery of Myrbetriq ER 50 mg tablets. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of October 13, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,185.76, is for the supply of Myrbetriq ER 50 mg tablets. The award has an ultimate completion date of March 22, 2024 and utilizes a firm fixed-price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,278.85 firm fixed-price delivery order is for the supply of the medication Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,555.04 delivery order is for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of June 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $15,284.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of May 14, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $1,096.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4563691628 Myrbetriq ER 25 mg tablets, with a completion date of February 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.54 firm fixed-price delivery order is for the supply of the pharmaceutical product Myrbetriq ER 50 mg Tablet, with a completion date of September 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,969.58 Firm Fixed Price Delivery Order contract is for the supply of Myrbetriq ER 50 mg tablets to support federal healthcare programs. It has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,590.49 firm-fixed-price delivery order, awarded on April 5, 2024, is for the supply of 4,564,185,600 tablets of the drug Myrbetriq ER 50 mg with an ultimate completion date of April 8, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...